Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 3Immunoglobulin Light-chain Amyloidosis 3Colorectal Neoplasms 3Breast Neoplasms 3Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Amyloidosis 2Waldenstrom Macroglobulinemia 1Urologic Neoplasms 1Tuberous Sclerosis 1Tissue Adhesions 1Skin Toxicity 1Sezary Syndrome 1Ras-wildtype Colorectal Cancer 1Polyps 1Polycystic Ovary Syndrome 1Pleural Neoplasms 1Pancreatic Neoplasms 1Pain 1Neurofibromatosis 2 1Neoplasms, Second Primary 1Myoma 1Menstruation Disturbances 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1

Interventions

Sirolimus 9Everolimus 3Imatinib Mesylate 2temsirolimus 1saracatinib 1nintedanib 1carbon-11 acetate 1Valproic Acid 1Urination 1Sugars 1Simvastatin 1Resveratrol 1Respiratory Function Tests 1Phlebotomy 1Loratadine 1Letrozole 1Immunoglobulin G 1Hydroxychloroquine 1Glutamine 1Genetic Testing 1Doxycycline 1Disulfides 1Cetuximab 1Celecoxib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphangioleiomyomatosis × Doxycycline × Clear all
NCT00989742 2015-12-02

Doxycycline In Lymphangioleiomyomatosis (LAM)

University of Nottingham

Phase 4 Completed
24 enrolled

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡